Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102674

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 9.5% from 2024-2032
Unit	Value (USD Billion)
Segmentation	By Drug Class Buprenorphine Methadone Naltrexone
	By Route of Administration Oral Parenteral
	By Distribution Channel Hospital Pharmacies Retail Pharmacies & Stores Online Pharmacies
	By Region North America (By Drug Class, By Route of Administration, By Distribution Channel, By Country) U.S. Canada Europe (By Drug Class, By Route of Administration, By Distribution Channel, By Country/sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Drug Class, By Route of Administration, By Distribution Channel, By Country/sub-region) Japan China India Australia South East Asia Rest of Asia Pacific Rest of the World (By Drug Class, By Route of Administration, By Distribution Channel)